Veritone Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Veritone (NASDAQ: VERI) has announced that its Board's Compensation Committee has granted an equity award to a new non-executive employee on April 2, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
This equity award consists of restricted stock units representing the right to receive upon vesting an aggregate of 60,000 shares of Veritone’s common stock.
The restricted stock units granted vest over a four-year period, in equal tranches on the anniversaries of the grant date, in each case subject to the employee’s continuous service with Veritone through the relevant vesting date. The new employee is not an executive officer of Veritone.
About Veritone
Veritone (NASDAQ: VERI) builds human-centered enterprise AI solutions. Serving customers in the media, entertainment, public sector and talent acquisition industries, Veritone’s software and services empower individuals at the world’s largest and most recognizable brands to run more efficiently, accelerate decision making and increase profitability. Veritone’s leading enterprise AI platform, aiWARE™, orchestrates an ever-growing ecosystem of machine learning models, transforming data sources into actionable intelligence. By blending human expertise with AI technology, Veritone advances human potential to help organizations solve problems and achieve more than ever before, enhancing lives everywhere. To learn more, visit Veritone.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250422922068/en/
Company:
Mike Zemetra
Chief Financial Officer
Veritone, Inc.
investors@veritone.com
IR Agency:
Cate Goldsmith
Prosek Partners
914-815-7678
cgoldsmith@prosek.com
Source: Veritone, Inc.